APA (7th ed.) Citation

BC, B., A, V., J, P., H, Y., P, H., K, W., . . . C, A. (2017). Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining Treg and antitumor CTL function. Science translational medicine, 9(372), . https://doi.org/10.1126/scitranslmed.aai8269

Chicago Style (17th ed.) Citation

BC, Betts, et al. "Targeting Aurora Kinase A and JAK2 Prevents GVHD While Maintaining Treg and Antitumor CTL Function." Science Translational Medicine 9, no. 372 (2017). https://doi.org/10.1126/scitranslmed.aai8269.

MLA (9th ed.) Citation

BC, Betts, et al. "Targeting Aurora Kinase A and JAK2 Prevents GVHD While Maintaining Treg and Antitumor CTL Function." Science Translational Medicine, vol. 9, no. 372, 2017, https://doi.org/10.1126/scitranslmed.aai8269.